Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Wolfgang von der Saal is active.

Publication


Featured researches published by Wolfgang von der Saal.


Journal of Medicinal Chemistry | 2011

Phthalazinone Pyrazoles as Potent, Selective, and Orally Bioavailable Inhibitors of Aurora-A Kinase

Michael Prime; Stephen Martin Courtney; Frederick Arthur Brookfield; Richard W. Marston; Victoria Walker; Justin Warne; Andrew E. Boyd; Norman Kairies; Wolfgang von der Saal; Anja Limberg; Guy Georges; Richard A. Engh; Bernhard Goller; Petra Rueger; Matthias Rueth

The inhibition of Aurora kinases in order to arrest mitosis and subsequently inhibit tumor growth via apoptosis of proliferating cells has generated significant discussion within the literature. We report a novel class of Aurora kinase inhibitors based upon a phthalazinone pyrazole scaffold. The development of the phthalazinone template resulted in a potent Aurora-A selective series of compounds (typically >1000-fold selectivity over Aurora-B) that display good pharmacological profiles with significantly improved oral bioavailability compared to the well studied Aurora inhibitor VX-680.


Bioorganic & Medicinal Chemistry Letters | 1997

DERIVATIVES OF 4-AMINO-PYRIDINE AS SELECTIVE THROMBIN INHIBITORS

Wolfgang von der Saal; Ralf Kucznierz; Herbert Leinert; Richard A. Engh

Abstract During screening for novel thrombin inhibitors it was discovered that the 4-aminopyridine derivative 1 inhibits human α-thrombin competitively and selectively. The 4-aminopyridine moiety itself is most likely the major determinant of the selectivity due to the increased hydrophobicity of the S1 pocket in thrombin compared to trypsin and plasmin. Optimization led to the selective thrombin inhibitor 14 with an inhibition constant, Ki of 70 nM.


Bioorganic & Medicinal Chemistry Letters | 1998

Diarylsulfonamides as selective, non-peptidic thrombin inhibitors

Ingo R. Weber; Richard Neidlein; Wolfgang von der Saal; Frank Grams; Herbert Leinert; Klaus Strein; Richard A. Engh; Ralf Kucznierz

Based on the structures of aminopyridine thrombin inhibitors (1), a series of aminoalkyl- and guanidinoalkyl-substituted diarylsulfonamides were prepared. The most potent derivative, N-[3-(4-guanidinobutoxy)-5-methyl-phenyl]-benzenesulfonamide (6c) had Ki = 0.18 microM for thrombin and did not inhibit trypsin, plasmin, or factor Xa. Comparison of the X-ray structures of the thrombin/1b and the thrombin/6c complexes revealed important aspects which govern the binding of such diarylsulfonamides to thrombin.


Synthetic Communications | 1999

Improved Procedures For Large Scale Preparation Of 6- and 7-Oxy-Substituted Isoquinolines and A Convenient Work-Up Protocol For Titanium Supported Reactions

Ralf Kucznierz; Joachim Dipl-chemi Dickhaut; Herbert Leinert; Wolfgang von der Saal

Abstract Improved procedures for large scale preparation of oxy-substituted isoquinoiines are reported. Moreover, a simple and convenient protocol for alkaline work-up of titanium containing reaction mixtures is given, which is expected to be of general interest even for reactions on a technical scale.


Journal of Medicinal Chemistry | 2002

Development of a virtual screening method for identification of "frequent hitters" in compound libraries.

Olivier Roche; Petra Schneider; Jochen Zuegge; Wolfgang Guba; Manfred Kansy; Alexander Alanine; Konrad Bleicher; Franck Danel; Eva-Maria Gutknecht; Mark Rogers-Evans; Werner Neidhart; Henri Stalder; Michael Patrick Dillon; Eric Brian Sjogren; Nader Fotouhi; Paul Gillespie; Robert Alan Goodnow; William Harris; Phil Jones; Mikio Taniguchi; Shinji Tsujii; Wolfgang von der Saal; Gerd Zimmermann; Gisbert Schneider


Structure | 1996

Enzyme flexibility, solvent and 'weak' interactions characterize thrombin-ligand interactions: implications for drug design.

Richard A. Engh; Hans Brandstetter; Gudrun Sucher; Andreas Eichinger; Ulrich Baumann; Wolfram Bode; Robert Huber; Thomas Poll; Rainer Rudolph; Wolfgang von der Saal


Archive | 1990

2-bicyclobenzimidazoles, processes for their preparation and medicaments containing these compounds

Wolfgang von der Saal; Harald Zilch; Erwin Böhm


Archive | 1986

Heterocyclic-substituted indoles and pharmaceutical compositions containing them

Alfred Mertens; Wolfgang von der Saal; Walter-Gunar Friebe; Bernd Muller-Beckmann; Gisbert Sponer


Journal of Medicinal Chemistry | 1989

Nonsteroidal cardiotonics. 2. The inotropic activity of linear, tricyclic 5-6-5 fused heterocycles

Wolfgang von der Saal; Jens Peter Hoelck; Wolfgang Kampe; Alfred Mertens; Bernd Mueller-Beckmann


Archive | 2002

Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors

Guy Georges; Adelbert Grossmann; Olaf Mundigl; Wolfgang von der Saal; Tim Sattelkau

Collaboration


Dive into the Wolfgang von der Saal's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge